Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Mid-range Performer
1662.5000 -6.90 (-0.41%)
NSE Jul 10, 2025 15:57 PM
Volume: 1.7M
 

logo
Sun Pharmaceutical Industries Ltd.
29 Oct 2024
1662.50
-0.41%
buy
by BOB Capital Markets Ltd.
Target: 2019 | Upside : 21.4%
BOB Capital Markets Ltd.
SUNP reported 11% domestic sales growth led by 5% volume growth from ~14,000 MRs; leads in Rx count across 13 doctor categories
 
Promoters pledged 0.19% of shares in last quarter. Total pledge stands at 0.88% of promoter holdings
More from Sun Pharmaceutical Industries Ltd.
Recommended
Market closes lower, SBI plans a Rs 25,000 crore share sale via a QIP
Trendlyne Marketwatch | 10 Jul 2025, 04:12PM
Five winners from analysts: Stocks set to start FY26 with a bang | Screener: Stocks analysts are most …
The Baseline | 10 Jul 2025, 12:14PM
Change is hard, and some Indian pharma companies are embracing it better than others
| 09 Aug 2022, 11:21AM